tetrahydrocurcumin has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bandivdekar, A; Degani, M; Kundaikar, H; Mirani, A; Patel, V; Patravale, V; Velhal, S | 1 |
1 other study(ies) available for tetrahydrocurcumin and HIV Coinfection
Article | Year |
---|---|
Tetrahydrocurcumin-loaded vaginal nanomicrobicide for prophylaxis of HIV/AIDS: in silico study, formulation development, and in vitro evaluation.
Topics: Administration, Intravaginal; Anti-Infective Agents; CD4-Positive T-Lymphocytes; Cell Line; Cell Survival; Curcumin; Drug Liberation; Emulsions; Gels; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Lacticaseibacillus casei; Lactobacillus acidophilus; Molecular Docking Simulation; Nanoparticles; Pre-Exposure Prophylaxis | 2019 |